Emergent BioSolutions (EBS) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $7.98 -0.87%
Revenue Growth %: +32.0%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
CCEL, MHGU, PLG, More
Revenue Growth %: +32.0%
Financial Fact:
Weighted-average number of shares - diluted: 49.44M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Emergent BioSolutions (NYSE: EBS) reported Q1 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $192.5 million versus the consensus estimate of $199.47 million.
For earnings history and earnings-related data on Emergent BioSolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Schneider National (SNDR) PT Raised to $34 at Stifel
- J.B. Hunt Transport Services (JBHT) PT Raised to $261 at Stifel Into Q2 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
